IT1246790B - Composizioni farmaceutiche per il trattamento del morbo di parkinson - Google Patents
Composizioni farmaceutiche per il trattamento del morbo di parkinsonInfo
- Publication number
- IT1246790B IT1246790B ITMI911048A ITMI911048A IT1246790B IT 1246790 B IT1246790 B IT 1246790B IT MI911048 A ITMI911048 A IT MI911048A IT MI911048 A ITMI911048 A IT MI911048A IT 1246790 B IT1246790 B IT 1246790B
- Authority
- IT
- Italy
- Prior art keywords
- parkinson
- disease
- treatment
- pharmaceutical compositions
- dopamine
- Prior art date
Links
- 208000018737 Parkinson disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- 102000004076 Dopamine D1 Receptors Human genes 0.000 abstract 1
- 108090000511 Dopamine D1 Receptors Proteins 0.000 abstract 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Vengono descritte composizioni farmaceutiche per il trattamento del morbo di Parkinson caratterizzate dal fatto che contengono come principi attivi in miscela precursori della dopamina e/o agonisti dei recettori alla dopamina D1 e antagonisti dell'N-metil-D-aspartato.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI911048A IT1246790B (it) | 1991-04-16 | 1991-04-16 | Composizioni farmaceutiche per il trattamento del morbo di parkinson |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI911048A IT1246790B (it) | 1991-04-16 | 1991-04-16 | Composizioni farmaceutiche per il trattamento del morbo di parkinson |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI911048A0 ITMI911048A0 (it) | 1991-04-16 |
ITMI911048A1 ITMI911048A1 (it) | 1992-10-16 |
IT1246790B true IT1246790B (it) | 1994-11-26 |
Family
ID=11359628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI911048A IT1246790B (it) | 1991-04-16 | 1991-04-16 | Composizioni farmaceutiche per il trattamento del morbo di parkinson |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1246790B (it) |
-
1991
- 1991-04-16 IT ITMI911048A patent/IT1246790B/it active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ITMI911048A0 (it) | 1991-04-16 |
ITMI911048A1 (it) | 1992-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9801305A (es) | Composicion de disolucion rapida oral para agonistas de dopamina. | |
AP1818A (en) | Urea-compounds active as vanilloid receptor antagonists for the treatment of pain | |
ZA921690B (en) | Compositions containing sumatriptan. | |
MD960330A (ro) | Compuşi nepeptidilici, compoziţie farmaceutică pe baza acestora, metodă de tratament | |
CA2108455A1 (en) | Pharmaceutical compositions against gastric disorders | |
BR1100776A (pt) | Forma de dosagem farmacêutica comprimida e obréia farmacêutica comprimida. | |
CA2246839A1 (en) | Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy | |
NZ522326A (en) | Adenosine A2A receptor antagonists | |
HU9603228D0 (en) | Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies | |
GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
EP0497258A3 (en) | Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer | |
GEP20053568B (en) | NMDA Receptor Agonist Pharmaceutical Compositions | |
BG104916A (en) | Calcilytic compounds | |
BG105256A (en) | Muscarinic agonists and antagonists | |
PL350568A1 (en) | N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors | |
AU655958B2 (en) | Use of quisqualate-receptor antagonists for treating Parkinson's disease | |
BG106548A (en) | Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog | |
GB2209281B (en) | Pharmaceutical compositions comprising an alpha-2 adrenoceptor antagonist | |
IT1246790B (it) | Composizioni farmaceutiche per il trattamento del morbo di parkinson | |
GEP20043377B (en) | Pharmaceutical Complex | |
GR3019776T3 (en) | Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof | |
DE69814669T2 (de) | Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten | |
UA27784C2 (uk) | Шипуча фармацевтична композиція для орального введення | |
ATE165737T1 (de) | Pharmazeutische zusammensetzungen, die 5-ht 1- rezeptoragonisten und absorptionsverstärker enthalten | |
IT1251993B (it) | Composizioni farmaceutiche ad uso orale,a base di esteri di gangliosidi,per il trattamento di neuropatie del sistema nervoso periferico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |